Five ferroptosis-related genes (SCP2, MUC1, DPP4, SLC1A4, and TF) were identified as promising diagnostic biomarkers for NAFLD. This evidence concerns the gene SLC1A4 and metabolic dysfunction-associated steatotic liver disease.